It is a global concern, with more than a billion people living with obesity around the world, according to estimates published in The Lancet in 2024
These are illustrated in figure 18
Many advertise GLP-1-like effects or claim to mimic Ozempic. None of these products contain authentic, pharmacologically active GLP-1 analogs
The dosing ranges and cycling patterns below are reported from published preclinical literature, clinic protocols, and community sources not approved prescribing guidelines
Its stimulant-free mechanism reduces the risk of anxiety or cardiovascular stress, making it suitable for a broader range of patient profiles , including those with type 2 diabetes or metabolic syndrome
But retatrutide also has the highest discontinuation rate (18.2% on 12mg vs